ISRCTN54358864.
Methods | RCT, cross‐over design |
Participants |
Inclusion criteria: at least 40 years old; BCVA of at least 20/25 in each eye; current multifocal SCL wearer; refraction distance sphere: −6.00 D to + 4.00 D; astigmatism: 0.00 D to −0.75 D; near addition: +0.75 D to +2.50 D Exclusion criteria: currently wearing study contact lenses; ocular condition(s) preventing contact lens wear; monocular correction; pregnant or lactating |
Interventions | Hioxifilcon A
Etafilcon A
|
Outcomes |
Primary outcome:
Secondary outcomes:
|
Notes | Sponsorship source: CooperVision Author's name: Deborah Moore Institution: Ocular Technology Group and CooperVision Comments: whether the analysis accounted for cross‐over design was unclear |